Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease

Su Hwan Lee, Jin Hwa Lee, Jung Hyun Chang, Soo Jung Kim, Hee Young Yoon, Sung Shine Shim, Min Uk Kim, Sun Young Choi, Yon Ju Ryu

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Background: Although infections caused by nontuberculous mycobacteria (NTM) are increasing in prevalence, there are few data about hemoptysis in patients with NTM lung disease. This study investigated the characteristics and prognosis of hemoptysis secondary to NTM infection. Methods: Following a retrospective review of cases managed between 2006 and 2016, 183 patients with NTM lung disease were enrolled and analyzed. Results: Among 183 patients with NTM lung disease, Mycobacterium intracellulare (n = 64, 35%) was the major cause of NTM infection, followed by M. avium (n = 59, 32.2%) and M. abscessus complex (n = 40, 21.9%). Hemoptysis developed in 78 patients (42.6%), among whom 33 (42.3%) required bronchial artery embolization (BAE). Between patients with and without hemoptysis, there were no significant differences with respect to sex, radiographic manifestations, distribution over 3 lobes on chest computed tomography, history of pulmonary tuberculosis, antiplatelet or anticoagulation therapy, and species of NTM. However, mean age at diagnosis was significantly lower in the hemoptysis group in univariate and multivariate analyses (65.7 ± 12.8 vs. 59.7 ± 11.8, P = 0.002, odds ratio: 0.969, 95% confidence interval: 0.944-0.996). Among patients with hemoptysis, those requiring medical therapy and those requiring BAE were not significantly different in terms of demographic characteristics, radiographic manifestations, and distribution over 3 lobes. All patients who received BAE showed immediate clinical improvement, no procedure-related complications, and none of them died during the period under review. Conclusions: NTM lung disease patients commonly experienced hemoptysis without specific risk factors except for relatively young age. Although some patients with hemoptysis needed BAE, the success rate of BAE was high, and there were no serious complications associated with BAE.

Original languageEnglish
Article number117
JournalBMC Pulmonary Medicine
Issue number1
StatePublished - 27 Jun 2019

Bibliographical note

Publisher Copyright:
© 2019 The Author(s).


  • Embolization
  • Hemoptysis
  • Mycobacterium infections
  • Tuberculosis
  • nontuberculous
  • therapeutic


Dive into the research topics of 'Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacterial lung disease'. Together they form a unique fingerprint.

Cite this